SNCA and Parkinson disease: Aggregation and (presumed) spreading of alpha-synuclein (α-syn) on the other hand clearly seem to constitute a critical event in PD pathophysiology and the recent failure of different monoclonal antibodies directed against aggregated α-syn in two therapeutic trails left the scientific community somewhat puzzled (Whone 2022).